Joon Lee
Stock Analyst at Truist Securities
(4.73)
# 144
Out of 4,969 analysts
111
Total ratings
58.72%
Success rate
42.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $520 → $490 | $396.62 | +23.54% | 4 | Aug 5, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $80 → $86 | $55.55 | +54.82% | 2 | Jul 29, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $95 → $75 | $26.83 | +179.54% | 8 | Apr 28, 2025 | |
| ARVN Arvinas | Maintains: Buy | $65 → $21 | $7.90 | +165.82% | 6 | Apr 9, 2025 | |
| CORT Corcept Therapeutics | Maintains: Buy | $76 → $150 | $71.34 | +110.26% | 8 | Mar 31, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $90 → $50 | $11.71 | +326.99% | 4 | Mar 4, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $175 → $85 | $46.70 | +82.01% | 5 | Mar 3, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $190 → $200 | $122.00 | +63.93% | 5 | Feb 19, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $100 → $120 | $52.98 | +126.50% | 5 | Feb 12, 2025 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $18 | $3.94 | +356.85% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $660 → $700 | $722.01 | -3.05% | 12 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $44 → $57 | $106.17 | -46.31% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.75 | +178.26% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $36 | $8.00 | +350.00% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $19.79 | +81.91% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $2.50 | +220.00% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $13.70 | +24.09% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $118 → $90 | $58.95 | +52.67% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $3.17 | +1,161.83% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $131.79 | +51.76% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $2.90 | +72.41% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.68 | +389.13% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $2.37 | +11,713.85% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $22.52 | +51.01% | 1 | Mar 16, 2021 |
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $520 → $490
Current: $396.62
Upside: +23.54%
PTC Therapeutics
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $55.55
Upside: +54.82%
Viking Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $26.83
Upside: +179.54%
Arvinas
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $7.90
Upside: +165.82%
Corcept Therapeutics
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $71.34
Upside: +110.26%
Intellia Therapeutics
Mar 4, 2025
Maintains: Buy
Price Target: $90 → $50
Current: $11.71
Upside: +326.99%
Praxis Precision Medicines
Mar 3, 2025
Maintains: Buy
Price Target: $175 → $85
Current: $46.70
Upside: +82.01%
Axsome Therapeutics
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $122.00
Upside: +63.93%
CRISPR Therapeutics AG
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $52.98
Upside: +126.50%
Larimar Therapeutics
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $3.94
Upside: +356.85%
Jan 14, 2025
Reiterates: Buy
Price Target: $660 → $700
Current: $722.01
Upside: -3.05%
Jan 8, 2025
Reiterates: Buy
Price Target: $44 → $57
Current: $106.17
Upside: -46.31%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $5.75
Upside: +178.26%
Nov 12, 2024
Maintains: Buy
Price Target: $17 → $36
Current: $8.00
Upside: +350.00%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $19.79
Upside: +81.91%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $2.50
Upside: +220.00%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $13.70
Upside: +24.09%
Sep 17, 2024
Maintains: Buy
Price Target: $118 → $90
Current: $58.95
Upside: +52.67%
Aug 14, 2024
Maintains: Buy
Price Target: $60 → $40
Current: $3.17
Upside: +1,161.83%
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $131.79
Upside: +51.76%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $2.90
Upside: +72.41%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $3.68
Upside: +389.13%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $2.37
Upside: +11,713.85%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $22.52
Upside: +51.01%